These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 22592833

  • 1. Colposcopy: still useful in microbicide safety trials?
    Mauck CK, Weiner DH, Lai JJ, Schwartz JL.
    Sex Transm Dis; 2012 Jun; 39(6):465-9. PubMed ID: 22592833
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase I safety & preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India.
    Joshi S, Joglekar N, Ghate M, Unni J, Risbud A, Bentley M, Shepherd M, Bollinger R, Mehendale S.
    Indian J Med Res; 2003 Apr; 117():152-7. PubMed ID: 14604303
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.
    J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluating the clinical safety of three vaginal applicators: a pilot study conducted in the Dominican Republic.
    Brache V, Cohen JA, Cochon L, Alvarez F.
    Contraception; 2006 Jan 01; 73(1):72-7. PubMed ID: 16371299
    [Abstract] [Full Text] [Related]

  • 12. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I, Taylor DJ.
    Sex Transm Dis; 2010 Jun 01; 37(6):361-4. PubMed ID: 20514687
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility to genital herpes as a biomarker predictive of increased HIV risk: expansion of a murine model of microbicide safety.
    Wilson SS, Cheshenko N, Fakioglu E, Mesquita PM, Keller MJ, Herold BC.
    Antivir Ther; 2009 Jun 01; 14(8):1113-24. PubMed ID: 20032541
    [Abstract] [Full Text] [Related]

  • 14. The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies.
    Poynten IM, Millwood IY, Falster MO, Law MG, Andresen DN, Van Damme L, Kaldor JM.
    AIDS; 2009 Jun 19; 23(10):1245-54. PubMed ID: 19474652
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Feasibility of radiolabeled small molecule permeability as a quantitative measure of microbicide candidate toxicity.
    Coleman JS, Fuchs E, Aung WS, Marzinke MA, Bakshi RP, Spiegel HML, Robinson J, Hendrix CW.
    Contraception; 2016 Apr 19; 93(4):331-336. PubMed ID: 26772905
    [Abstract] [Full Text] [Related]

  • 20. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies.
    Scorpio DG, Ruben DS, Liao Z, Hildreth JE, Fletcher CA.
    J Med Primatol; 2008 Feb 19; 37 Suppl 1():65-73. PubMed ID: 18269532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.